MERCADOLIBRE INC (MELI) Fundamental Analysis & Valuation

NASDAQ:MELI • US58733R1023

1769.52 USD
-18.34 (-1.03%)
At close: Mar 9, 2026
1762.5 USD
-7.02 (-0.4%)
After Hours: 3/9/2026, 7:54:59 PM

This MELI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MELI. MELI was compared to 30 industry peers in the Broadline Retail industry. MELI scores excellent on profitability, but there are some minor concerns on its financial health. MELI is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes MELI very considerable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. MELI Profitability Analysis

1.1 Basic Checks

  • MELI had positive earnings in the past year.
  • MELI had a positive operating cash flow in the past year.
  • MELI had positive earnings in each of the past 5 years.
  • In the past 5 years MELI always reported a positive cash flow from operatings.
MELI Yearly Net Income VS EBIT VS OCF VS FCFMELI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

1.2 Ratios

  • MELI has a Return On Assets of 4.68%. This is in the better half of the industry: MELI outperforms 63.33% of its industry peers.
  • Looking at the Return On Equity, with a value of 29.59%, MELI belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.
  • MELI's Return On Invested Capital of 16.97% is amongst the best of the industry. MELI outperforms 90.00% of its industry peers.
  • MELI had an Average Return On Invested Capital over the past 3 years of 21.88%. This is significantly above the industry average of 9.12%.
  • The 3 year average ROIC (21.88%) for MELI is well above the current ROIC(16.97%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.68%
ROE 29.59%
ROIC 16.97%
ROA(3y)5.96%
ROA(5y)4.44%
ROE(3y)35.22%
ROE(5y)27.5%
ROIC(3y)21.88%
ROIC(5y)17.77%
MELI Yearly ROA, ROE, ROICMELI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.91%, MELI is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of MELI has grown nicely.
  • MELI has a better Operating Margin (11.08%) than 80.00% of its industry peers.
  • MELI's Operating Margin has improved in the last couple of years.
  • MELI's Gross Margin of 44.50% is in line compared to the rest of the industry. MELI outperforms 56.67% of its industry peers.
  • In the last couple of years the Gross Margin of MELI has remained more or less at the same level.
Industry RankSector Rank
OM 11.08%
PM (TTM) 6.91%
GM 44.5%
OM growth 3Y3.76%
OM growth 5Y28.09%
PM growth 3Y15.63%
PM growth 5YN/A
GM growth 3Y-2.64%
GM growth 5Y0.68%
MELI Yearly Profit, Operating, Gross MarginsMELI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

6

2. MELI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MELI is creating value.
  • Compared to 1 year ago, MELI has about the same amount of shares outstanding.
  • Compared to 5 years ago, MELI has more shares outstanding
  • The debt/assets ratio for MELI has been reduced compared to a year ago.
MELI Yearly Shares OutstandingMELI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
MELI Yearly Total Debt VS Total AssetsMELI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 2.77 indicates that MELI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.77, MELI perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
  • MELI has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
  • MELI has a better Debt to FCF ratio (0.85) than 83.33% of its industry peers.
  • MELI has a Debt/Equity ratio of 0.68. This is a neutral value indicating MELI is somewhat dependend on debt financing.
  • MELI has a Debt to Equity ratio of 0.68. This is in the lower half of the industry: MELI underperforms 63.33% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for MELI, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 0.85
Altman-Z 2.77
ROIC/WACC1.9
WACC8.95%
MELI Yearly LT Debt VS Equity VS FCFMELI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.17 indicates that MELI should not have too much problems paying its short term obligations.
  • MELI has a worse Current ratio (1.17) than 73.33% of its industry peers.
  • MELI has a Quick Ratio of 1.15. This is a normal value and indicates that MELI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.15, MELI perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.15
MELI Yearly Current Assets VS Current LiabilitesMELI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

8

3. MELI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.51% over the past year.
  • The Earnings Per Share has been growing by 60.44% on average over the past years. This is a very strong growth
  • The Revenue has grown by 39.06% in the past year. This is a very strong growth!
  • MELI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.70% yearly.
EPS 1Y (TTM)4.51%
EPS 3Y60.44%
EPS 5YN/A
EPS Q2Q%-12.53%
Revenue 1Y (TTM)39.06%
Revenue growth 3Y38.91%
Revenue growth 5Y48.7%
Sales Q2Q%44.56%

3.2 Future

  • Based on estimates for the next years, MELI will show a very strong growth in Earnings Per Share. The EPS will grow by 35.40% on average per year.
  • The Revenue is expected to grow by 19.27% on average over the next years. This is quite good.
EPS Next Y48.52%
EPS Next 2Y43.89%
EPS Next 3Y40.95%
EPS Next 5Y35.4%
Revenue Next Year32.19%
Revenue Next 2Y27.48%
Revenue Next 3Y24.27%
Revenue Next 5Y19.27%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MELI Yearly Revenue VS EstimatesMELI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
MELI Yearly EPS VS EstimatesMELI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 100 200 300

4

4. MELI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 44.91, the valuation of MELI can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of MELI is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 26.46, MELI is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 30.24, the valuation of MELI can be described as expensive.
  • MELI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. MELI is more expensive than 63.33% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of MELI to the average of the S&P500 Index (24.65), we can say MELI is valued slightly more expensively.
Industry RankSector Rank
PE 44.91
Fwd PE 30.24
MELI Price Earnings VS Forward Price EarningsMELI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • MELI's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MELI indicates a somewhat cheap valuation: MELI is cheaper than 80.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.33
EV/EBITDA 22.62
MELI Per share dataMELI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of MELI may justify a higher PE ratio.
  • MELI's earnings are expected to grow with 40.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.93
PEG (5Y)N/A
EPS Next 2Y43.89%
EPS Next 3Y40.95%

0

5. MELI Dividend Analysis

5.1 Amount

  • MELI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MELI Fundamentals: All Metrics, Ratios and Statistics

MERCADOLIBRE INC

NASDAQ:MELI (3/9/2026, 7:54:59 PM)

After market: 1762.5 -7.02 (-0.4%)

1769.52

-18.34 (-1.03%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)02-24
Earnings (Next)05-07
Inst Owners82.1%
Inst Owner Change-1.19%
Ins Owners0.26%
Ins Owner Change0%
Market Cap89.71B
Revenue(TTM)28.89B
Net Income(TTM)2.00B
Analysts84.52
Price Target2854.36 (61.31%)
Short Float %1.66%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.17%
Min EPS beat(2)-12.64%
Max EPS beat(2)-5.7%
EPS beat(4)1
Avg EPS beat(4)-4.66%
Min EPS beat(4)-15.3%
Max EPS beat(4)14.99%
EPS beat(8)4
Avg EPS beat(8)5.59%
EPS beat(12)7
Avg EPS beat(12)3.94%
EPS beat(16)10
Avg EPS beat(16)6.86%
Revenue beat(2)2
Avg Revenue beat(2)1.02%
Min Revenue beat(2)0.61%
Max Revenue beat(2)1.44%
Revenue beat(4)3
Avg Revenue beat(4)1.88%
Min Revenue beat(4)-0.1%
Max Revenue beat(4)5.59%
Revenue beat(8)6
Avg Revenue beat(8)3%
Revenue beat(12)10
Avg Revenue beat(12)2.83%
Revenue beat(16)13
Avg Revenue beat(16)3.26%
PT rev (1m)-0.36%
PT rev (3m)-1.39%
EPS NQ rev (1m)-10.02%
EPS NQ rev (3m)-15.5%
EPS NY rev (1m)-4.47%
EPS NY rev (3m)-6.37%
Revenue NQ rev (1m)3.93%
Revenue NQ rev (3m)5.72%
Revenue NY rev (1m)2.41%
Revenue NY rev (3m)3.24%
Valuation
Industry RankSector Rank
PE 44.91
Fwd PE 30.24
P/S 3.11
P/FCF 8.33
P/OCF 7.4
P/B 13.3
P/tB 13.69
EV/EBITDA 22.62
EPS(TTM)39.4
EY2.23%
EPS(NY)58.52
Fwd EY3.31%
FCF(TTM)212.49
FCFY12.01%
OCF(TTM)238.97
OCFY13.51%
SpS569.88
BVpS133.1
TBVpS129.23
PEG (NY)0.93
PEG (5Y)N/A
Graham Number343.5
Profitability
Industry RankSector Rank
ROA 4.68%
ROE 29.59%
ROCE 22.81%
ROIC 16.97%
ROICexc 30.8%
ROICexgc 31.6%
OM 11.08%
PM (TTM) 6.91%
GM 44.5%
FCFM 37.29%
ROA(3y)5.96%
ROA(5y)4.44%
ROE(3y)35.22%
ROE(5y)27.5%
ROIC(3y)21.88%
ROIC(5y)17.77%
ROICexc(3y)229.5%
ROICexc(5y)162.58%
ROICexgc(3y)538.3%
ROICexgc(5y)354.16%
ROCE(3y)29.4%
ROCE(5y)23.88%
ROICexgc growth 3Y-33.3%
ROICexgc growth 5YN/A
ROICexc growth 3Y-28.99%
ROICexc growth 5YN/A
OM growth 3Y3.76%
OM growth 5Y28.09%
PM growth 3Y15.63%
PM growth 5YN/A
GM growth 3Y-2.64%
GM growth 5Y0.68%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 0.85
Debt/EBITDA 1.14
Cap/Depr 164.18%
Cap/Sales 4.65%
Interest Coverage 5.24
Cash Conversion 301.47%
Profit Quality 539.46%
Current Ratio 1.17
Quick Ratio 1.15
Altman-Z 2.77
F-Score5
WACC8.95%
ROIC/WACC1.9
Cap/Depr(3y)133.57%
Cap/Depr(5y)162.49%
Cap/Sales(3y)4.05%
Cap/Sales(5y)5%
Profit Quality(3y)459.33%
Profit Quality(5y)464.07%
High Growth Momentum
Growth
EPS 1Y (TTM)4.51%
EPS 3Y60.44%
EPS 5YN/A
EPS Q2Q%-12.53%
EPS Next Y48.52%
EPS Next 2Y43.89%
EPS Next 3Y40.95%
EPS Next 5Y35.4%
Revenue 1Y (TTM)39.06%
Revenue growth 3Y38.91%
Revenue growth 5Y48.7%
Sales Q2Q%44.56%
Revenue Next Year32.19%
Revenue Next 2Y27.48%
Revenue Next 3Y24.27%
Revenue Next 5Y19.27%
EBIT growth 1Y21.66%
EBIT growth 3Y44.14%
EBIT growth 5Y90.47%
EBIT Next Year64.21%
EBIT Next 3Y41.72%
EBIT Next 5Y30.45%
FCF growth 1Y52.64%
FCF growth 3Y63.06%
FCF growth 5Y63.03%
OCF growth 1Y53.02%
OCF growth 3Y60.33%
OCF growth 5Y59.26%

MERCADOLIBRE INC / MELI FAQ

What is the fundamental rating for MELI stock?

ChartMill assigns a fundamental rating of 6 / 10 to MELI.


What is the valuation status of MERCADOLIBRE INC (MELI) stock?

ChartMill assigns a valuation rating of 4 / 10 to MERCADOLIBRE INC (MELI). This can be considered as Fairly Valued.


Can you provide the profitability details for MERCADOLIBRE INC?

MERCADOLIBRE INC (MELI) has a profitability rating of 8 / 10.


How financially healthy is MERCADOLIBRE INC?

The financial health rating of MERCADOLIBRE INC (MELI) is 6 / 10.


Can you provide the dividend sustainability for MELI stock?

The dividend rating of MERCADOLIBRE INC (MELI) is 0 / 10 and the dividend payout ratio is 0%.